Could cures for cancer lie hidden in the cloud? - BBC News

When Hollywood actress Angelina Jolie found out she carried the BRCA1 gene, her doctors told her she had an 87% chance of developing breast cancer. Armed with this knowledge, she chose to undergo a double mastectomy in 2013 to reduce the risk to around 5%. This kind of genetic testing can now be done much faster and at lower cost, giving clinicians the ability to target treatments more effectively. And combining this technological breakthrough with cloud computing and artificial intelligence is giving pharmaceutical companies the tools to develop drugs faster and with greater chance of success. One beneficiary of this new approach is Eric Dishman, founder of tech giant Intel's first health research and innovation laboratory in 1999 and a founding member of its digital health group in 2005.